未登录

M

Maja Lang Balija

university of zagreb

H指数:14

被引数:528

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Insertion of a short non-viral sequence in the 3′ noncoding region of the hemagglutinin-neuraminidase increases mumps virus neurovirulence

在血凝素-神经氨酸酶的3′非编码区插入短的非病毒序列会增加腮腺病毒的神经毒力。

IF2.4

2025-03-010

PRE

Pharmacokinetics of Snake Antivenom Following Intravenous and Intramuscular Administration in Envenomed Large Animal Model

IF5.5

2025-02-070

OAAI

Evaluation of the Interactions between Mumps Virus and Guinea Pig

JOURNAL OF VIROLOGY

IF3.8

2023-04-271

OAAI

Comparison of Preclinical Properties of Several Available Antivenoms in the Search for Effective Treatment of Vipera ammodytes and Vipera berus Envenoming

IF4

2021-03-139

OAAI

Quality-Related Properties of Equine Immunoglobulins Purified by Different Approaches

IF4

2020-12-148

OAAI

Biological Activities and Proteomic Profile of the Venom of Vipera ursinii ssp., a very Rare Karst Viper from Croatia

IF4

2020-03-1611

OAAI

Refinement strategy for antivenom preparation of high yield and quality

高产优质抗蛇毒血清制剂的精制策略

PLOS NEGLECTED TROPICAL DISEASES

IF3.4

2019-06-1718

OAAI

Concept of sample-specific correction of immunoassay results for precise and accurate IgG quantification in horse plasma

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2019-02-016

PREAI

Comment on Antivenom for European Vipera species envenoming

CLINICAL TOXICOLOGY

IF3.3

2018-03-090

PREAI

Vipera ammodytes bites treated with antivenom ViperaTAb: a case series with pharmacokinetic evaluation

CLINICAL TOXICOLOGY

IF3.3

2017-01-1721

PREAI

A Single Dose of Viperfav™ May Be Inadequate for Vipera ammodytes Snake Bite: A Case Report and Pharmacokinetic Evaluation

IF4

2016-08-1913

OAAI

Factors influencing preclinical in vivo evaluation of mumps vaccine strain immunogenicity

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2015-09-166

OAAI

Structural and biochemical characterisation of VaF1, a P-IIIa fibrinogenolytic metalloproteinase from Vipera ammodytes ammodytes venom

IF3

2015-02-0110

PREAI

Identification of proteins interacting with ammodytoxins in Vipera ammodytes ammodytes venom by immuno-affinity chromatography

ANALYTICAL AND BIOANALYTICAL CHEMISTRY

IF3.8

2013-11-1218

PREAI

VaH3, one of the principal hemorrhagins in Vipera ammodytes ammodytes venom, is a homodimeric P-IIIc metalloproteinase

IF3

2013-06-0125

PREAI

Intraspecies variability in Vipera ammodytes ammodytes venom related to its toxicity and immunogenic potential

COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY

IF4.3

2011-03-0121

PREAI

Ammodytoxin content of Vipera ammodytes ammodytes venom as a prognostic factor for venom immunogenicity

COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY

IF4.3

2010-05-017

PREAI

The role of antibodies specific for toxic sPLA2s and haemorrhagins in neutralizing potential of antisera raised against Vipera ammodytes ammodytes venom

COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY

IF4.3

2008-08-0116

PREAI

Dose dependent effects of standardized nose-homed viper (Vipera ammodytes ammodytes) venom on parameters of cardiac function in isolated rat

COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY

IF4.3

2008-05-017

PREAI

The variability of Vipera ammodytes ammodytes venoms from Croatia -: biochemical properties and biological activity

COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY

IF4.3

2005-02-0126

PREAI